Covidence website will be inaccessible as we upgrading our platform on Monday 23rd August at 10am AEST, / 2am CEST/1am BST (Sunday, 15th August 8pm EDT/5pm PDT)
We are on a mission to change the way the world creates and uses trustworthy knowledge. We have seen sustained growth in the demand for high-quality evidence over many years, as well as the increasingly sophisticated skills necessary to respond to this demand.
As we continue to build Covidence, as a platform that accelerates the creation of high-quality evidence to speeds previously unimaginable, we also want to contribute to building opportunities and skills in our community.
This is why we are proud to launch the Covidence Global Scholarship Program in 2022. To support the next generation of superstar evidence researchers around the world. We recognize how difficult it can be to get funding to pursue academic projects, even ones that are a high priority for our society.
So we are helping to take some of the financial burden away so some of the world’s brightest PhD and Masters students can spend more time creating knowledge that will make a big impact in the world.
Check below for this year’s recipients.
Annie Tan
Deakin University |Women’s experiences of the indirect impacts of COVID-19 on maternal and perinatal health.
Dina Indriss-Wheeler
University of Ottawa | Interventions directed at men for preventing intimate partner violence.
Edessa Dumessa
Haramaya University | Community-level antibiotic access and use practices in selected sub-districts of Harar and Haramaya, Eastern Ethiopia.
Aatik Arsh
University of York United Kingdom
Antonio Bognanni
McMaster University
Bereket Gebremichael Menota
Adelaide University
Fahmida Saadia Rahman
Western Sydney University
Mojgan Amiri
Erasmus Medical Center (EMC), Rotterdam, The Netherlands.
Olivia Magwood
University of Ottawa
Sarah Jacobs
The University of Cape Town
Abdul Cadri
Asma Zaheer
Benjamin Lazarus
Bianca Varney
Caitlin Jones
Cenjing Zhu
Chelsea Moran
Cristián Mansilla
Deepanjali Behera
Dilruba Fatima Sharmin
El Zahraa Majed
Elizabeth Hitches
Eman Alzghoul
Emily Bell
Emma Perris
Erynn Monette
Eugene Wong
Francisca Verdugo
Habtamu Kasaye
Habte Gobie
Hamufare Mugauri
Iris Martine Blom
Irvin Kendall
Israel Dabengwa
Ludoviko Zirimenya
Lyra Egan
Matthew Douma
Mmalehu Pelwane Mavis Mohuba
Mohammad Moharrami
Nirjhar Ghosh
Ogochukwu Onyeso
Priyanka Dubey
Qusai Khraisha
Roya Karimi
Sarah Morris
Shahrzad Motaghi
Tafirenyika Gwenzi
Thomasina Donovan
Timothy Olusegun Olanrewaju
Vanessa Cho
Virginia Margarita Sanguinetti Elizondo
Yaoyao Qian
To everyone who applied for this scholarship program you are making a huge difference to evidence-based practice and policy and we applaud your efforts. We wish you the best of luck with your studies and want nothing more than for you to succeed with your research.
There are 3 award tiers.
The first tier will award 3 recipients with $15,000 each
The second tier will award 7 recipients with $2,500 each
The third tier will award 42 recipients with a free single subscription to the Covidence platform valued at $240 each.
Awards are once off and contingent upon the applicant being enrolled at an accredited college or university and meeting all other eligibility criteria.
Applicants to the Covidence Global Scholarship must meet all of the following criteria:
The applications open on Feb 21st 2022 and will remain open until 31st March 11.59pm EST (8:59pm PST – 1st April 3:59pm AEDT 4:59am GST)
We will be awarding 52 scholarships in total as per the tiering:
Tier 1 – 3
Tier 2 – 7
Tier 3 – 42
Please email:comms@covidence.org
You can read the full terms and conditions here
The expectation from the review committee is that you would be expected to be actually working on the systematic review in the second half of the calendar year.
Seeking Expressions of Interest from qualified individuals to serve on our Scholarship selection panel. Closing date for expressions of interest: Thursday, 31 March 2022, 5pm GMT
By using our site you consent to our use of cookies to measure and improve our site’s performance. Please see our Privacy Policy for more information.